Skip to main content
. 2018;19(9):2625–2630. doi: 10.22034/APJCP.2018.19.9.2625

Table 3.

Distribution of Genotype and Allele Frequencies of ATG16L1 Polymorphism in Patients with Bladder Cancer (BCa) and Healthy Controls

Gene/Genotypes Patients n=69 n/% Control n=156 n/% P value Odds ratio 95% (CI)
ATG16L1
AA 24 (35) 50 (32) - 1 -
AG 28 (40) 62 (40) 0.856 0.941 0.486-1.821
GG 17 (25) 44 (28) 0.566 0.805 0.383-1.690
A 76 (55) 162 (52)
Alleles G 62 (45) 150 (48) 0.537 1.135 0.759-1.697